1. Home
  2. QNCX vs SHIM Comparison

QNCX vs SHIM Comparison

Compare QNCX & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • SHIM
  • Stock Information
  • Founded
  • QNCX 2012
  • SHIM 1990
  • Country
  • QNCX United States
  • SHIM United States
  • Employees
  • QNCX N/A
  • SHIM N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • SHIM
  • Sector
  • QNCX Health Care
  • SHIM
  • Exchange
  • QNCX Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • QNCX 47.7M
  • SHIM 53.7M
  • IPO Year
  • QNCX 2019
  • SHIM 2023
  • Fundamental
  • Price
  • QNCX $1.68
  • SHIM $1.89
  • Analyst Decision
  • QNCX Strong Buy
  • SHIM Hold
  • Analyst Count
  • QNCX 5
  • SHIM 2
  • Target Price
  • QNCX $8.00
  • SHIM $3.00
  • AVG Volume (30 Days)
  • QNCX 235.8K
  • SHIM 80.3K
  • Earning Date
  • QNCX 08-12-2025
  • SHIM 08-14-2025
  • Dividend Yield
  • QNCX N/A
  • SHIM N/A
  • EPS Growth
  • QNCX N/A
  • SHIM N/A
  • EPS
  • QNCX N/A
  • SHIM N/A
  • Revenue
  • QNCX N/A
  • SHIM $482,303,000.00
  • Revenue This Year
  • QNCX N/A
  • SHIM $1.12
  • Revenue Next Year
  • QNCX N/A
  • SHIM $7.50
  • P/E Ratio
  • QNCX N/A
  • SHIM N/A
  • Revenue Growth
  • QNCX N/A
  • SHIM N/A
  • 52 Week Low
  • QNCX $0.51
  • SHIM $1.30
  • 52 Week High
  • QNCX $2.45
  • SHIM $4.94
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 50.83
  • SHIM 46.18
  • Support Level
  • QNCX $1.75
  • SHIM $2.00
  • Resistance Level
  • QNCX $2.05
  • SHIM $2.16
  • Average True Range (ATR)
  • QNCX 0.16
  • SHIM 0.14
  • MACD
  • QNCX -0.02
  • SHIM -0.03
  • Stochastic Oscillator
  • QNCX 9.76
  • SHIM 8.51

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: